Furthermore, these trained DCs exhibited higher CD86 expression, and the CTB-trained mice displayed an effective antitumor immunity against melanoma challenge, associated with a robust infiltration of highly co-stimulatory DCs and functional CD8 T cells. Here, CD8A is linked to melanoma.